EXEL

EXELIXIS INC

EXEL·30161Q104·US·Common Stock·Healthcare - Biotechnology-Activist

EXEL (EXELIXIS INC) is held by 246 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.3B), RENAISSANCE TECHNOLOGIES LLC ($588.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($562.3M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 123 funds bought EXEL.

246
Holders
(24 Elite)
$9.7B
Total Value
51% (241)
Consensus
123 buying - 118 selling
13F: Insider & Congress:
EXEL

Smart Money Verdict

View all
Held by 246 funds
24 elite

Who's Trading

InsiderFCFreire Maria CExercise 21K shMay 7, 2026
InsiderPGPOSTE GEORGESell $2.7MMay 7, 2026
InsiderFCFreire Maria CSell $949KMay 7, 2026
InsiderBCBeckerle Mary CExercise 4K shMay 7, 2026
InsiderBCBeckerle Mary CSell $374KMay 7, 2026
InsiderMMMORRISSEY MICHAELGift 110K shMay 6, 2026
ActivistVAVanguard Capital Management5.1%Apr 29, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderADAftab DanaSell $2.1MFeb 24, 2026
CongressRohit KhannaRohit KhannaBuy $15,001 - $50,000Jan 10, 2024

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
30.8M(+2.0%)$1.3B0.0%+65.57%
33
Decreased
13.7M(-1.3%)$588.8M0.9%+176.59%
0
Decreased
13.1M(-16.5%)$562.3M3.2%+146.11%
0
Decreased
13.1M(-4.1%)$561.7M0.3%+56.56%
0
New
12.1M$518.3M0.0%+38.68%
43
New
11.3M$482.9M0.0%+38.68%
43
Decreased
10.3M(-1.8%)$441.7M0.0%+131.59%
0
Increased
8.5M(+7.3%)$366.4M1.2%+99.48%
53
Increased
7.8M(+3.5%)$334.4M0.0%+118.17%
32
Decreased
4.8M(-8.4%)$207.4M0.1%+65.91%
0
Decreased
4.3M(-28.7%)$185M0.0%+72.08%
0
Increased
4.3M(+0.9%)$184.4M0.0%+155.05%
31
Decreased
4.2M(-0.7%)$179.2M0.0%+67.37%
0
Increased
3.8M(+55.6%)$162.2M0.0%+46.11%
43
Increased
3.6M(+93.7%)$154.5M0.1%+36.79%
48
Increased
3.4M(+1.8%)$145.4M0.3%+39.48%
37
Increased
3.1M(+174.3%)$133.1M0.5%+49.19%
69
Decreased
2.5M(-5.8%)$109.1M0.2%+65.98%
0
Increased
2.5M(+62.0%)$108.7M0.1%+91.16%
43
Decreased
2.4M(-35.7%)$102.7M0.0%+47.58%
0

Showing 1-20 of 256

1 / 13

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used